Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients
Parental prostacyclin is the only therapy with a proven survival benefit in pulmonary arterial hypertension (PAH).However, some patients are unable to Vacuum Tool Adaptor Set tolerate continuous prostacyclin infusion because of central line infection, side effects, or sociocultural factors.Selexipag is a recently approved prostacyclin receptor agon